19-17830035-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000534444.1(JAK3):​c.3280G>T​(p.Ala1094Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000106 in 939,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/17 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1094T) has been classified as Likely benign. The gene JAK3 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000011 ( 0 hom. )

Consequence

JAK3
ENST00000534444.1 missense

Scores

2
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.41

Publications

0 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000534444.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05902937).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000534444.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK3
NM_000215.4
MANE Select
c.3207+73G>T
intron
N/ANP_000206.2
JAK3
NM_001440439.1
c.3207+73G>T
intron
N/ANP_001427368.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK3
ENST00000534444.1
TSL:1
c.3280G>Tp.Ala1094Ser
missense
Exon 23 of 23ENSP00000436421.1P52333-2
JAK3
ENST00000458235.7
TSL:5 MANE Select
c.3207+73G>T
intron
N/AENSP00000391676.1P52333-1
JAK3
ENST00000527670.5
TSL:1
c.3207+73G>T
intron
N/AENSP00000432511.1P52333-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000106
AC:
1
AN:
939714
Hom.:
0
Cov.:
13
AF XY:
0.00000208
AC XY:
1
AN XY:
481422
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
22690
American (AMR)
AF:
0.00
AC:
0
AN:
35166
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70116
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41022
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4818
European-Non Finnish (NFE)
AF:
0.00000150
AC:
1
AN:
666930
Other (OTH)
AF:
0.00
AC:
0
AN:
42872
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.51
DANN
Benign
0.93
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.24
T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-0.88
T
PhyloP100
-2.4
PROVEAN
Benign
0.51
N
REVEL
Benign
0.088
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs536358097;
hg19: chr19-17940844;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.